Pharmacist support 24/7

Select Language

Opdyta Nivolumab 100mg Injection Vial 10ml 1's

Manufacturer: BRISTOL MYERS SQUIBB

Salt: NIVOLUMAB 100MG

Category: Anti-Cancer

Price: $1299

Availability: In Stock

Opdyta 100mg Injection consists of the active substance Nivolumab. It is indicated to treat cancers of the skin, lungs, kidney, lymph node, bladder, esophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognize and attack cancer cells. By blocking these molecules, it helps to enhance the immune response against cancer and potentially shrink or slow the growth of tumors. 


One of the benefits of it and other immunotherapy drugs is that they can produce long-lasting responses in some patients, even after the treatment is stopped. This contrasts traditional chemotherapy and radiation therapy, which typically only provide temporary benefits and can have significant side effects. It is contraindicated in patients with a severe allergic reaction to the drug or its components. It is also contraindicated in patients with certain autoimmune disorders, such as lupus or rheumatoid arthritis because the drug can further stimulate the immune system and exacerbate these conditions. Additionally, it should be used cautiously in patients with a history of organ transplants.

Advanced skin cancer (melanoma)

Skin cancer that recurs after surgery

Advanced non-small cell lung cancer

Advanced kidney cancer

Hodgkin’s lymphoma (lymph node disease)

Advanced cancer of the head and neck

Advanced urinary tract and bladder cancer

Advanced esophageal cancer

In Stock
Opdyta Nivolumab 100mg Injection Vial 10ml 1's
(4.8/5) 124 reviews
Medically Reviewed
Pharmacist Verified

Opdyta Nivolumab 100mg Injection Vial 10ml 1's

ManufacturerBRISTOL MYERS SQUIBB
Salt CompositionNIVOLUMAB 100MG
Anti Cancer
Sale Price
$1299$1558.80
20% OFF
1

Product Information

What is Opdyta Nivolumab 100mg Injection Vial 10ml 1's?

Opdyta 100mg Injection consists of the active substance Nivolumab. It is indicated to treat cancers of the skin, lungs, kidney, lymph node, bladder, esophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognize and attack cancer cells. By blocking these molecules, it helps to enhance the immune response against cancer and potentially shrink or slow the growth of tumors. 


One of the benefits of it and other immunotherapy drugs is that they can produce long-lasting responses in some patients, even after the treatment is stopped. This contrasts traditional chemotherapy and radiation therapy, which typically only provide temporary benefits and can have significant side effects. It is contraindicated in patients with a severe allergic reaction to the drug or its components. It is also contraindicated in patients with certain autoimmune disorders, such as lupus or rheumatoid arthritis because the drug can further stimulate the immune system and exacerbate these conditions. Additionally, it should be used cautiously in patients with a history of organ transplants.

Indications for Opdyta Nivolumab 100mg Injection Vial 10ml 1's

Advanced skin cancer (melanoma)

Skin cancer that recurs after surgery

Advanced non-small cell lung cancer

Advanced kidney cancer

Hodgkin’s lymphoma (lymph node disease)

Advanced cancer of the head and neck

Advanced urinary tract and bladder cancer

Advanced esophageal cancer

Therapeutic Effects of Opdyta Nivolumab 100mg Injection Vial 10ml 1's

The therapeutic effect of Opdyta 100mg Injection is to enhance the body's natural immune response to cancer cells. Cancer cells can often evade the immune system by producing proteins that bind to immune cells and prevent them from recognizing and attacking the cancer cells. It works by blocking the interaction between a protein called programmed death-1 (PD-1), found on the surface of immune cells, and its corresponding ligands. Doing so enables the immune system to recognize and attack cancer cells more effectively, helping to slow down or even stop cancer progression. In some cases, treatment with it can lead to long-lasting remission, even after treatment has ended. This is because the drug can stimulate the immune system to "remember" the cancer cells and continue to attack them even after the drug has been cleared from the body.

How to consume Opdyta Nivolumab 100mg Injection Vial 10ml 1's

Opdyta 100mg Injection is a medication a healthcare professional administers, typically in a hospital or clinic setting. The medication is given as an intravenous (IV) infusion by healthcare professional. The infusion typically takes several hours. You will be closely monitored during and after the infusion to ensure the medication works effectively and to watch for any side effects. The dosage and frequency of administration will depend on the condition being treated and your circumstances. Your healthcare provider will determine the appropriate dosage and schedule for you.

Side Effects of Opdyta Nivolumab 100mg Injection Vial 10ml 1's

Pneumonitis (inflammation of lung tissue)

Colitis (inflammation of the colon)

Hepatitis (inflammation of the liver)

Hypothyroidism

Hyperthyroidism

Adrenal insufficiency (a condition in which the adrenal glands do not produce enough hormones).

Severe allergic reactions

Infusion-related reactions

Confusion

Seizures

Neuropathy

Eye disorders (such as uveitis or iritis)

Fatigue

Nausea

Skin rash

Itching

Loss of appetite

Diarrhea

Constipation

Joint pain

Headache

Drug Interactions

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Opdyta 100mg Injection and reduce effectiveness by causing undesirable side effects.

Storage & Handling

Opdyta 100mg Injection is typically supplied in vials or pre-filled syringes and should be stored at controlled room temperature between 20-25°C (68-77°F).

The drug should be protected from light and should not be frozen.

Once the vial or syringe is opened, any unused portion should be discarded. It is important to follow the manufacturer's instructions for handling and storage of it to ensure that the drug is effective and safe for use.

Expert Advice

If you are considering or receiving Opdyta 100mg Injection treatment, it is important to discuss the potential risks and benefits of the treatment with your healthcare provider. It is also important to follow all safety precautions and guidelines provided by your healthcare provider to minimize any potential risks associated with treatment. Be sure to report any new or worsening symptoms to your healthcare provider promptly, as some side effects can be serious and require immediate medical attention. Suppose you are a woman of reproductive age should use effective contraception during and for at least 5 months after the last dose of it to avoid potential harm to a developing fetus. Remember to take care of yourself and priorities self-care during treatment. This can include eating a healthy diet, getting enough rest, and seeking support from loved ones or support groups.

Worldwide Shipping & Delivery

We provide specialized tracked delivery for Opdyta Nivolumab 100mg Injection Vial 10ml 1's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.

  • USA Shipping
  • UK Delivery
  • UAE & Middle East
  • Germany & EU
  • Australia
  • Canada

Professional Safety Guidelines for Opdyta Nivolumab 100mg Injection Vial 10ml 1's

Pregnancy
Pregnancy
Unsafe

Opdyta 100mg Injection is unsafe for a developing foetus and is not recommended during pregnancy as it can cause harm to the developing foetus.

BreastFeeding
BreastFeeding
Consult your doctor

It is unknown whether Opdyta 100mg Injection is excreted in human breast milk, so a breastfeeding woman should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.

Liver
Liver
Unsafe

Opdyta 100mg Injection should be used cautiously in individuals with liver disease, as the medication is primarily metabolized in the liver and could potentially worsen liver function. Your healthcare provider will monitor you closely if you have liver disease and adjust your dosage if necessary.

Lungs
Lungs
Unsafe

Opdyta 100mg Injection should be used cautiously in individuals with lung disease, as the medication can potentially worsen lung function. Your healthcare provider will monitor you closely if you have lung disease and adjust your dosage if necessary. If you have lung disease or a history of respiratory problems, discussing the potential risks and benefits of treatment with your healthcare provider is important. Your healthcare provider may recommend additional monitoring or testing to ensure the medication is not causing any adverse effects on your lungs.

Alcohol
Alcohol
Consult your doctor

There are no known interactions between Opdyta 100mg Injection and alcohol. However, it is generally recommended to avoid consuming alcohol while being treated for a medical condition, as alcohol can potentially interfere with the effectiveness of the medication and increase the risk of side effects.

Driving
Driving
Unsafe

Patients receiving Opdyta 100mg Injection should avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Similar Medications

View All